Arcaro A - Search Results

1

Targeting mTOR signaling in lung cancer.

Marinov M, Fischer B, Arcaro A. Marinov M, et al. Among authors: arcaro a. Crit Rev Oncol Hematol. 2007 Aug;63(2):172-82. doi: 10.1016/j.critrevonc.2007.04.002. Epub 2007 May 30. Crit Rev Oncol Hematol. 2007. PMID: 17540577 Review.

2

Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms.

Katso RM, Pardo OE, Palamidessi A, Franz CM, Marinov M, De Laurentiis A, Downward J, Scita G, Ridley AJ, Waterfield MD, Arcaro A. Katso RM, et al. Among authors: arcaro a. Mol Biol Cell. 2006 Sep;17(9):3729-44. doi: 10.1091/mbc.e05-11-1083. Epub 2006 Jun 14. Mol Biol Cell. 2006. PMID: 16775008 Free PMC article.

3

IGF-IR: potential role in antitumor agents.

Guerreiro AS, Boller D, Doepfner KT, Arcaro A. Guerreiro AS, et al. Among authors: arcaro a. Drug News Perspect. 2006 Jun;19(5):261-72. doi: 10.1358/dnp.2006.19.5.985933. Drug News Perspect. 2006. PMID: 16941048 Free article. Review.

4

Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibition.

Guerreiro AS, Boller D, Shalaby T, Grotzer MA, Arcaro A. Guerreiro AS, et al. Among authors: arcaro a. Int J Cancer. 2006 Dec 1;119(11):2527-38. doi: 10.1002/ijc.22126. Int J Cancer. 2006. PMID: 16988940 Free article.

5

Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?

Fischer B, Marinov M, Arcaro A. Fischer B, et al. Among authors: arcaro a. Cancer Treat Rev. 2007 Jun;33(4):391-406. doi: 10.1016/j.ctrv.2007.01.006. Epub 2007 Mar 26. Cancer Treat Rev. 2007. PMID: 17368733 Review.

6

Novel role for insulin as an autocrine growth factor for malignant brain tumour cells.

Arcaro A, Doepfner KT, Boller D, Guerreiro AS, Shalaby T, Jackson SP, Schoenwaelder SM, Delattre O, Grotzer MA, Fischer B. Arcaro A, et al. Biochem J. 2007 Aug 15;406(1):57-66. doi: 10.1042/BJ20070309. Biochem J. 2007. PMID: 17506723 Free PMC article.

7

Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.

Doepfner KT, Spertini O, Arcaro A. Doepfner KT, et al. Among authors: arcaro a. Leukemia. 2007 Sep;21(9):1921-30. doi: 10.1038/sj.leu.2404813. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581609

8

Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.

Doepfner KT, Boller D, Arcaro A. Doepfner KT, et al. Among authors: arcaro a. Crit Rev Oncol Hematol. 2007 Sep;63(3):215-30. doi: 10.1016/j.critrevonc.2007.05.005. Epub 2007 Jul 19. Crit Rev Oncol Hematol. 2007. PMID: 17658267 Review.

9

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

Boller D, Schramm A, Doepfner KT, Shalaby T, von Bueren AO, Eggert A, Grotzer MA, Arcaro A. Boller D, et al. Among authors: arcaro a. Clin Cancer Res. 2008 Feb 15;14(4):1172-81. doi: 10.1158/1078-0432.CCR-07-0737. Clin Cancer Res. 2008. PMID: 18281552 Free article.

10

Current status of clinical trials for small cell lung cancer.

Fischer B, Arcaro A. Fischer B, et al. Among authors: arcaro a. Rev Recent Clin Trials. 2008 Jan;3(1):40-61. doi: 10.2174/157488708783330503. Rev Recent Clin Trials. 2008. PMID: 18474014 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page